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ComplicationsAbstract Objectives: To determine the complications associated with Port A Cath insertion in
cancer patients.
Methods: The records 250 patients, who received a subcutaneous port catheter between 2009 and
2013, were analyzed retrospectively with regard to implantation complications and complications in
the course of Port A Cath use.
Results: The average duration over which the Port A Cath remained in place was 22 months.
Postoperative complications occurred in 29 patients (11.6%); of these, 4 (1.6%) were perioperative
and 25 (10%) were long-term complications.
Perioperative complications were in the form of inadvertent arterial rupture. Long-term complica-
tions included the following: infection in 10 patients (4%), mechanical failure in 5 patients (2%),
thrombosis in 4 patients (1.6%), suture disruption in 3 patients (1.2%), extravasation in 2 patients
(0.8%), and catheter migration in one patient (0.4%).
Conclusion: Port A Cath implantation is associated with some risk of serious complications. Care
of the catheter and the patient should be maintained to decrease the risk of complications.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Modern chemotherapeutic management depends upon
repeated and safe access to the venous system for the delivery
of drugs, ﬂuids and blood products and on the periodicmonitoring of the effects of treatment (1). Peripheral veins
are rapidly destroyed by repeated venipuncture and by long
term chemotherapy (2). The long-term venous access devices
(VADs) have helped to overcome the need for repeated
peripheral or central venous puncture (3).
One frequently employed type of venous access system is
the Port A Cath system. The Port A Cath is a totally implan-
table venous access device in which a conventional central
venous catheter is attached to a subcutaneous injection port
usually on the chest wall (4).
The usage of ports for a wide variety of indications has also
brought a wide spectrum of complications that are well docu-
mented in the existing literature (5–9).
908 A.M.A. Samad, Y.A. IbrahimThe purpose of this study is to determine the immediate and
long-term complications of Port A Cath insertion and to see
whether the complication rate was comparable to what was
reported in the literature.Table 1 Sites of insertion of Port A Cath.
Site of insertion Total number of patients
Right internal jugular vein 197
Left internal jugular vein 31
Right subclavian vein 14
Left subclavian vein 8
Total 2502. Materials and methods
After institutional board approval, the records 250 patients,
who received a subcutaneous port catheter between 2009 and
2013, were analyzed retrospectively with regard to the implan-
tation complications and complications in the course of
Port A Cath use. The type of devices used, and the indication
for placement and the side of implantation were recorded.
2.1. Technique of Port A Cath implantation
All port catheter implantations were performed by interven-
tional radiologists by using a Port A Cath kit Titanium
(Medcomp) or polyurethane (B. BRAUN, France).
The procedure was done under local anesthesia using 20 cc
of Xylocaine diluted with 10 cc normal saline. The puncture
site was anesthetized using 10 cc of the diluted xylocaine.
Puncture of the internal jugular vein (IJV) or subclavian
vein (SCV) was done under ultrasound guidance with linear
probe 8 MHz (LOGIQ 5, General Electric Health Care
Medical Systems, USA). Followed by the insertion of the guide
wire under ﬂuoroscopic guidance (Artis Zee Siemens
Germany) into the right atrium, a bell-away sheath was
inserted over the wire under ﬂuoroscopic guidance.
The catheter was then irrigated with saline and kept closed
and then inserted through the bell away sheath to the right
atrium level after removal of the guide wire followed by
Belling of the sheath under ﬂuoroscopic guidance.
The site of port implantation was anaesthetized with 20 cc
diluted xylocaine. A ±2 cm incision was done two ﬁngers
below the mid aspect of the clavicle. A cavity was done in
the subcutaneous tissue that could accommodate the port
chamber. Tunneling was made in between this cavity and the
puncture site to bypass the catheter through it. The tip of
the catheter was adjusted to the level of the junction between
the SVC and the right atrium under ﬂuoroscopic guidance.
The catheter was then connected to the port chamber with a
plastic or metallic lock. The port was tested with heparinized
saline (aspiration and then injection). The subcutaneous tissue
was closed with 02 vicryl suture followed by closure of the skin
with 02 silk suture. Post procedure chest X-ray was done to
document the port place. The overall procedure time took
15–45 min.
The technique was done under general anesthesia in only
two patients due to severe patient anxiety.
2.2. Statistical analysis
Analysis of data was done by IBM computer using SPSS (sta-
tistical program for social science version 12) as follows
 Description of quantitative variables as mean and range.
 Description of qualitative variables as number and
percentage.3. Results
Of the 250 implantations, 167 were females (66.8%) and 83
males (33.2%). Mean age was 50 yrs (range 16–73 yrs).
Percutaneous Seldinger method was used in all patients
with the insertion of titanium ports in 183 patients (73.2%)
and polyurethane types of ports in 67 patients (26.8%). All
patients had underlying malignant conditions. Breast cancer
was the most common underlying diagnosis (56.4%), followed
by gastrointestinal tract malignancies (26%). The port catheter
was inserted for chemotherapeutic treatment of the primary
disease in 95 patients (38%), and for control of metastatic dis-
ease in 155 patients (62%).
The most common site of insertion was the right internal
jugular vein (78.8%), followed by the left internal jugular vein.
The details are shown in Table 1.
The average duration over which the Port A Cath remained
in place was 22 months (range 6–60 months).
Post-operative complications occurred in 29 patients
(11.6%) (Table 2); of these, 4 were perioperative and 25 were
long-term complications.
4. Discussion
Central venous port catheters are usually set on the purpose of
periodic administration of chemotherapy for the treatment of
various malignancies.
Placing these devices completely under the skin allows the
patient to continue a normal life without special care, other
than monthly heparinized serum infusion. The introduction
of any foreign object into the body, however, is accompanied
by technical difﬁculties and the risk of developing complica-
tions (10). Although the advantages of PVAD use outweigh
the disadvantages (11), PVAD-related complications can be
very serious.
In this study, the overall incidence of Port A Cath-related
complications was 11.6% and two types of complications were
distinguished: immediate perioperative (1.6%) and long-term
complications (10%).
Immediate perioperative complications were recorded in
previous studies (12–14), and their rate was ranging between
1.7% and 20.5%. The complications were in the form of pneu-
mothorax, hemorrhage, catheter malposition and catheter
embolization.
In our study, inadvertent arterial rupture with consequent
neck hematoma was the only immediate perioperative compli-
cation encountered. It occurred in 4 cases. All were managed
by conservative measures (intermittent compression and
ultrasound follow up).
Table 2 Complications associated with the implantation of
Port A Cath.
Perioperative complication %
Inadvertent arterial puncture with neck hematoma 1.6 (n= 4)
Long term complications %
Infection 4 (n= 10)
Mechanical failure 2 (n= 5)
Venous thrombosis 1.6 (n= 4)
Suture disruption 1.2 (n= 3)
Port separation with extravasation 0.8 (n= 2)
Catheter migration 0.4 (n= 1)
Fig. 1 Suture disruption after local inﬂammation (A), treated by
AB therapy, trimining of the edge and resuturing (B).
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bosis, extravasation and catheter fracture have been described
as 0.0–55.5% in the literature (14).
Our Port A Cath related Late complications were infec-
tions, mechanical failure, suture disruption, thrombosis, cathe-
ter migration and port separation with extravasation in a rate
of 10%.
Catheter related infections were seen in ten patients (4%);
of these ten, nine (3.6%) were exit-site infection and one
(0.4%) was an isolated pocket infection. The causative
microorganism was Staphylococcal species in eight out of ten
infections. PVAD-associated infection should not always lead
to catheter removal and can be treated with antibiotics speciﬁc
to the causative organism and local care (15). In our study,
because of progressive infection despite antibiotic treatment,
the infected PVADs were removed. This is in conformity with
other studies which have shown catheter-related infection as
the cause of premature removal in 7.1–13.4% of cases (16–18).
Several studies have reported premature removal due to
device failure to occur in 2.9–3.4% of VADs (16–18); a nearly
similar incidence was seen in our patients (2%). There are
some reports that the use of continuous prophylactic anticoag-
ulant therapy reduces the incidence of VAD failure (19–21).
In four patients (1.6%), catheter thrombosis occurred and
was successfully treated by heparin and oral anticoagulant
drugs and catheter function restoration was achieved.
Suture disruption was found in three patients (1.2%) and
was managed by trimining of the edges followed by resuturing
(Fig. 1).
Extravasation occurred in two patients (0.8%) and com-
prised subcutaneous leakage of the cytostatics (or cytotoxic)
at the port site. Local symptoms included erythema and
edema, without ulceration or necrosis. All were treated
conservatively and infusion was restarted successfully. The
extravasation rate of 0.8% found in our study is comparable
with that in the literature (0.9–6.5%) (14,22).
Port A Catheter fracture with fragment dislodgement
occurs in approximately 0.2–1% of port catheter implantation
(23–25). The dislocated catheter fragments have been found
mainly in central veins, including subclavian vein, superior
vena cava, inferior vena cava, right atrium, right ventricle,
and pulmonary artery. Port A Catheter fracture is often
asymptomatic (24). However, serious complications such as
infection, pulmonary embolism, arrhythmia, cardiac arrest
and cardiac perforation occasionally pursue (26–28).
The prevalence of Catheter fragmentation at the time of
placement has decreased after the introduction of the changefrom a needle to a sheath and guide wire usage (21). Delayed
fragmentation with or without embolization can be caused
by too medial positioning, angulation or distortion of the
anastomosis between port and catheter, severing of the cathe-
ter during insertion procedure, and fatigue of the catheter (29).
The ‘‘pinch off syndrome’’ is the most common cause due to
the catheter wear secondary to tearing and scissoring effect
between the clavicle and ﬁrst rib during shoulder movement
(30).
In our study, delayed catheter fracture occurred in one
patient (0.4%). It was suspected by the failure to aspire blood
and detection on a chest X-ray. The broken catheter segment
migrated to the pulmonary artery 175 days after implantation.
The fragment was removed with the Amplatz snare device
by catheterization under local anesthesia via the femoral vein
(Fig. 2).
In conclusion, the implantation and use of PVADs is a
reliable and valuable method for long-term intravenous
therapy, with a complication rate of 11.6% in our study which
is largely comparable to the published data. However, there is
a need to reduce the catheter related complications. Sufﬁcient
Fig. 2 Chest radiography (A), CT chest in lung (B) and mediastinal (C) window settings with 3D reconstruction (D), showing the
migrated catheter lodged in the pulmonary artery.
910 A.M.A. Samad, Y.A. Ibrahiminformation prior to implantation should be given and with
appropriate follow up after implantation for patient satisfac-
tion and the early recognition of complications.
Conﬂict of interest
We have no conﬂict of interest to declare.
References
(1) Reed WP, Newman KA, Jongh CD, et al. Prolonged venous
access for chemotherapy by means of the Hickman catheter.
Cancer 1993;52:185–92.
(2) Neiderhuber JE, Ensminger W, Gyves JW, et al. Totally
implanted venous and arterial access system to replace external
catheters in cancer treatment. Surgery 1982;92:706–12.
(3) Burney A, Akbar MT, Bhatti FN, Siddiqui T, Khurshaidi n,
Sophie z. Complications of in dwelling venous access devices: a
single institution experience. JPMA 2001;51:434.
(4) Lambert ME, Chadwick GA, McMahon A, Scarife H. Experience
with the portacath. Haematol Oncol 1988;6:57–63.(5) Krupski G, Froschie GW, Weh FJ, Schlosser GA. Central venous
access devices in treatment of patients with malignant tumors:
venous port, central venous catheter and Hickmann catheter.
Cost beneﬁt analysis based on a critical review of the literature,
personal experiences with 135 port implantations and patient
attitude. Chirurgie 1995;66:202–7.
(6) C¸il BE, Canyig˘it M, Peynirciog˘lu B, et al. Subcutaneous venous
port implantation in adult patients: a single center experience.
Diagn Interv Radiol 2006;12:93–8.
(7) Denny MA, Frank LR. Ventricular tachycardia secondary to
port-a-cath fracture and embolization. J Emerg Med 2003;24:
29–34.
(8) Dysarz FA, Fiorillo MA, Davidson PG. Complications of
subcutaneous injection ports. Mt Sinai J Med 1998;65:289–91.
(9) Malm T, Eliasson H, Johansson S, et al. Tricuspid valve
stenosis––a serious complication ot port-a-cath. Lakartidningen
2005;102:3318–21.
(10) Erog˘lu E, Bulutc¸u E, Erc¸elen O¨. Unusual complications of the
subcutaneous port catheter. J New Zealand Med Assoc 2008;121:
1280.
(11) Hartkamp A, van Boxtel AJH, Zonnenberg BA, Witteven PO.
Totally implantable venous access devices: evaluation of
Complications of Port A Cath implantation 911complications and a prospective comparative study of two
different port systems. Neth J Med 2000;57:215–23.
(12) Yildizeli B, Lac¸in T, Batirel HF, Yu¨ksel M. Complications and
management of long-term central venous access catheters and
ports. J Vasc Access 2004;5:174–8.
(13) Lefrant JY, Muller L, Coussaye JE, et al. Risk factors of failure
and immediate complication of subclavian vein catheterization in
critically ill patients. Intensive Care Med 2002;28:1036–41.
(14) Lemmers NWM, Gels ME, Sleijfer DT, et al. Complications of
venous access ports in 132 patients with disseminated testicular
cancer treated with polychemotherapy. J Clin Oncol 1996;14:
2916–22.
(15) Keung Y, Watkins K, Chen S, et al. Comparative study of
infectious complications of different types of chronic central
venous access devices. Cancer 1994;73:2832–7.
(16) Ray S, Stacey R, Imrie M, Filshie J. A review of 560 Hickman
catheter insertions. Anaesthesia 1996;51:981–5.
(17) Schwartz RE, Groeger JS, Coit DG. Subcutaneously implanted
central venous access devices in cancer patients. Cancer 1997;79:
1635–40.
(18) Schuman E, Ragsdale J. Peripheral ports are a new option for
central venous access. J Am Coll Surg 1995;180:456–60.
(19) Weber DR. Is heparin really necessary in the lock and if so, how
much? DICP 1991;25:399–407.
(20) Pucheu A, Dierhas M, Leduc B, et al. Fibrinolysis of deep venous
thrombosis on implantable perfusion devices. Apropos of a
consecutive series of 57 cases of thrombosis and 32 cases of
ﬁbrinolysis. Bull Cancer 1996;83:293–9.
(21) Denny Jr DF. Placement and management of long term central
venous access catheters and ports. Am J Roentgenol 1993;161:
385–93.(22) Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP. Evaluation of
an implantable venous access system in a general oncology
population. Oncology 1992;49:474–8.
(23) Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable
vascular access system: experience in 1500 patients with totally
implanted central venous port system. World J Surg 1998;22:
12–6.
(24) Surov A, Jordan K, Buerke M, Persing M, Wollschlaeger B,
Behrmann C. Atypical pulmonary embolism of port catheter
fragments in oncology patients. Support Care Cancer 2006;14:
479–83.
(25) Koller M, Papa MZ, Zweig A, Ben-Ari G. Spontaneous leak and
transection of permanent subclavian catheters. J Surg Oncol
1998;68:166–8.
(26) Ballarini C, Intra M, Pisani Ceretti A, et al. Complications of
subcutaneous infusion port in the general oncology population.
Oncology 1999;56:97–102.
(27) Monreal M, Davant E. Thrombotic complications of central
venous catheters in cancer patients. Acta Haematol 2001;106:
69–72.
(28) Gowda MR, Gowda RM, Khan IA, et al. Positional ventricular
tachycardia from a fractured mediport catheter with right
ventricular migration––a case report. Angiology 2004;55:557–60.
(29) Liu JC, Tseng HS, Chen CY, Chern MS, Chang CY.
Percutaneous retrieval of 20 centrally dislodged port-A catheter
fragments. Clin Imaging 2004;28:223–9.
(30) Hinke DH, Zandt-Stastny DA, Goodman LR, Quebbeman EJ,
Krzywda EA, Andris DA. Pinch-off syndrome: a complication of
implantable subclavian venous access devices. Radiology 1990;
177:353–6.
